simvastatin has been researched along with Arterial Occlusive Diseases in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 14 (63.64) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoppe, C; Jacob, E; Kuypers, F; Larkin, S; Styles, L; Vichinsky, E | 1 |
| Armitage, J; Bowman, L; Collins, R; Gut, I; Heath, S; Lathrop, M; Link, E; Matsuda, F; Parish, S | 1 |
| Ockene, IS | 1 |
| Armitage, J; Clarke, R; Collins, R; Hill, MR; Hopewell, JC; Offer, A; Otvos, JD; Parish, S | 1 |
| Kuller, LH; Mackey, RH | 1 |
| Chiariello, M; Curcio, A; Indolfi, C | 1 |
| Farmer, JA | 1 |
| Benson, G; Berry, GJ; Faul, JL; Kao, PN; Nishimura, T; Pearl, RG; Qiu, D; Shi, L; Vaszar, LT; Zhao, G | 1 |
| Kröger, K; Wittlinger, T | 1 |
| Armitage, J; Collins, R; Parish, S; Peto, R; Sleight, P | 1 |
| Bieroń, K; Goszcz, A; Grodzińska, L; Korbut, R; Starzyk, D | 1 |
| Kellomäki, M; Keski-Nisula, L; Mikkonen, J; Nevalainen, T; Parkkinen, J; Salenius, JP; Törmälä, P; Uurto, I | 1 |
| Bucek, RA; Minar, E; Pourazim, A; Reiter, M; Wirth, S | 1 |
| Armitage, J; Briggs, A; Collins, R; Gray, A; Mihaylova, B; Parish, S | 1 |
| Ikeda, U; Shimada, K; Shimpo, M | 1 |
| Heckbert, SR; Weiss, NS | 1 |
| Crook, MA; Jackson, G; Reynolds, TM; Wierzbicki, AS | 1 |
| Dalkara, T; Endres, M; Huang, PL; Huang, Z; Laufs, U; Liao, JK; Moskowitz, MA; Waeber, C; Yamada, M | 1 |
| Bisicchia, A; Di Salvo, MM; Ferlito, S; Gallina, M; Mugno, F | 1 |
| Bom, N; Gussenhoven, EJ; Hagenaars, T; Jukema, JW; Kranendonk, SE; van Sambeek, MR | 1 |
| Asahara, T; Bahlmann, FH; Isner, JM; Kirchmair, R; Losordo, DW; Murayama, T; Nishimura, H; Rittig, K; Silver, M; Walter, DH | 1 |
1 review(s) available for simvastatin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
[Role of lipid lowering therapy in patients with peripheral arterial occlusive disease].
Topics: Anticholesteremic Agents; Arterial Occlusive Diseases; Atorvastatin; Disease Progression; Exercise Test; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Jejunoileal Bypass; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Simvastatin; Treatment Outcome | 2004 |
7 trial(s) available for simvastatin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.
Topics: Adolescent; Adult; Analgesics; Anemia, Sickle Cell; Arterial Occlusive Diseases; Biomarkers; C-Reactive Protein; Child; E-Selectin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Male; Nitric Oxide; Pain; Simvastatin; Vascular Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A; Young Adult | 2017 |
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.
Topics: Arterial Occlusive Diseases; Chemical and Drug Induced Liver Injury; Death, Sudden, Cardiac; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Muscular Diseases; Myocardial Infarction; Myocardial Reperfusion; Niacin; Simvastatin; Stroke | 2013 |
SLCO1B1 variants and statin-induced myopathy--a genomewide study.
Topics: Aged; Arterial Occlusive Diseases; Chromosomes, Human, Pair 12; Diabetes Mellitus; Female; Genetic Markers; Genotype; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Muscular Diseases; Myocardial Infarction; Organic Anion Transporters; Polymorphism, Single Nucleotide; Risk; Simvastatin | 2008 |
Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
Topics: Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Arterial Occlusive Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Placebos; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Simvastatin | 2012 |
Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.
Topics: Adult; Aged; Anticholesteremic Agents; Arterial Occlusive Diseases; Brain Ischemia; Cerebrovascular Disorders; Cholesterol, LDL; Clinical Trials as Topic; Coronary Disease; Female; Humans; Incidence; Male; Middle Aged; Peripheral Nervous System Diseases; Placebos; Simvastatin; Stroke; Treatment Outcome | 2004 |
Simvastatin effects in normo- and hypercholesterolaemic patients with peripheral arterial occlusive disease: a pilot study.
Topics: Aged; Ankle; Anticholesteremic Agents; Arterial Occlusive Diseases; Blood Coagulation Tests; Blood Pressure; Blood Pressure Determination; Brachial Artery; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Exercise Test; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Platelet Aggregation; Serum Globulins; Simvastatin; Triglycerides | 2005 |
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people.
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Coronary Disease; Cost-Benefit Analysis; Diabetic Angiopathies; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Expectancy; Male; Middle Aged; Quality-Adjusted Life Years; Risk Factors; Simvastatin | 2006 |
14 other study(ies) available for simvastatin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Déjà vu all over again.
Topics: Arterial Occlusive Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Humans; Male; Simvastatin | 2012 |
Letter by Kuller and Mackey regarding article, "Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection study".
Topics: Arterial Occlusive Diseases; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Dyslipidemias; Female; Humans; Male; Simvastatin | 2012 |
Simvastatin reduces neointimal thickening after experimental angioplasty.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; MAP Kinase Signaling System; Mice; Proto-Oncogene Proteins p21(ras); Rats; Simvastatin | 2003 |
Benefits of simvastin in cholesterol lowering.
Topics: Anticholesteremic Agents; Arterial Occlusive Diseases; Cholesterol, LDL; Coronary Disease; Diabetes Mellitus; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Simvastatin; Stroke; United Kingdom | 2003 |
Simvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cells.
Topics: Animals; Apoptosis; Arterial Occlusive Diseases; Cell Division; Gene Expression Profiling; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Pulmonary; Hypertrophy; Hypertrophy, Right Ventricular; Lung; Muscle, Smooth, Vascular; Pulmonary Artery; Rats; Simvastatin; Survival Analysis; Tunica Intima | 2003 |
Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.
Topics: Absorbable Implants; Animals; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Coated Materials, Biocompatible; Dexamethasone; Disease Models, Animal; Follow-Up Studies; Glucocorticoids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Iliac Artery; Male; Pilot Projects; Polyesters; Prosthesis Design; Simvastatin; Stents; Swine | 2005 |
Influence of HMG-CoA-reductase inhibitors on the body fat status.
Topics: Adipose Tissue; Aged; Arterial Occlusive Diseases; Atorvastatin; Body Composition; Body Mass Index; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Retrospective Studies; Simvastatin | 2006 |
Thrombotic vascular events after change of statin.
Topics: Anticholesteremic Agents; Arterial Occlusive Diseases; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Simvastatin; Thrombosis | 1999 |
Thrombotic vascular events after change of statin.
Topics: Anticholesteremic Agents; Arterial Occlusive Diseases; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Simvastatin; Thrombosis | 1999 |
Thrombotic vascular events after change of statin.
Topics: Anticholesteremic Agents; Arterial Occlusive Diseases; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Indoles; Simvastatin; Thrombosis | 1999 |
Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment.
Topics: Animals; Arginine; Arterial Occlusive Diseases; Cerebral Arteries; Cerebrovascular Circulation; Drug Synergism; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Simvastatin; Time Factors | 2000 |
Plasma levels of E-selectin in normolipemic and hyperlipemic arteriopathic patients after vasoactive and lipid-lowering treatment.
Topics: Arterial Occlusive Diseases; Bezafibrate; E-Selectin; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Simvastatin; Vasoconstrictor Agents | 2000 |
Effect of simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Arterial Occlusive Diseases; Chemotherapy, Adjuvant; Female; Femoral Artery; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Popliteal Artery; Retrospective Studies; Simvastatin; Ultrasonography, Interventional | 2000 |
Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Bone Marrow Transplantation; Carotid Stenosis; Cell Adhesion; Cell Division; Cell Movement; Cells, Cultured; Endothelium, Vascular; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Integrins; Kinetics; Male; Mice; Rats; Rats, Sprague-Dawley; Simvastatin | 2002 |